The New York Times

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology. By Christina Jewett and ...
The Washington Post

Inside RFK Jr.’s push against the flu vaccine that he links to his voice condition

Health Secretary Robert F. Kennedy Jr. has spent years campaigning against vaccines, but with the flu shot, he’s suggested it’s personal. Kennedy has linked his strained, raspy speech to the vaccine, ...
CNBC

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application. The FDA is slated to make a ...
Yahoo

Inside RFK Jr.’s long-running crusade against the flu vaccine

Health Secretary Robert F. Kennedy Jr. has spent years campaigning against vaccines, but with the flu shot, he’s suggested it’s personal. Kennedy has linked his strained, raspy speech to the vaccine, ...
CNN

FDA reverses course and will review Moderna’s mRNA flu shot, company says

The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday. About two weeks ago, the FDA sent Moderna a ...
CBS News

Moderna says FDA will now review its new flu vaccine, reversing earlier decision

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...
NPR

Despite U.S. pull out from WHO, reps were (virtually) at the table for big flu confab

For the past week, about 50 flu scientists from around the world were crammed into a conference room at a Hilton hotel in Istanbul, Turkey. Their goal was to design a flu shot that will confer the ...
The Boston Globe

FDA reverses course, will review Moderna flu shot after controversial refusal

The Food and Drug Administration will review Moderna’s new flu vaccine after initially refusing to review the candidate, the Cambridge biotech announced early Wednesday. The FDA’s decision not to ...
Detroit News

FDA reverses course and will review Moderna’s mRNA-based flu shot

The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said ...
Scientific American

FDA agrees to review Moderna mRNA flu vaccine in dramatic reversal

The U.S. Food and Drug Administration will review a messenger RNA (mRNA) flu vaccine for approval, according to its maker, Moderna. The decision is a dramatic U-turn for the agency, which, only about ...
The Conversation

FDA’s abrupt flip‑flop on Moderna’s mRNA flu shot highlights growing risks to drug‑makers of investing in vaccines

Ana Santos Rutschman does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...